Verapamil
VERELAN PM
Calcium Channel Blocker
NADAC/unit
$0.0630
No Shortage
Tier 1: 480.9%
19 Manufacturers
43 ANDAs
INDICATIONS AND USAGE Verapamil Hydrochloride Tablets are indicated for the treatment of the following: Angina 1.
vs. brand VERELAN PM: Generic saves up to 99% per unit
Active Shortages
2025-11-21 Discontinuation of the manufacture of the drug, Pfizer Inc.
Market Intelligence
2024-07-17 Class III Recall: Zydus Pharmaceuticals (USA) Inc
2024-07-17 Class III Recall: Zydus Pharmaceuticals (USA) Inc
Generic Manufacturers
AMNEAL EU LTDASPIRO PHARMA LTDAZURITY PHARMACEUTICALS INCCADILA PHARMACEUTICALS LTDCAPLIN STERILES LTDEUGIA PHARMA SPECIALITIES LTDEXELA PHARMA SCIENCES LLCFRESENIUS KABI USA LLCGLAND PHARMA LTDGLENMARK PHARMACEUTICALS LTDHERITAGE PHARMACEUTICALS INC DBA AVET PHARMACEUTICALS INCHOSPIRA INCMANKIND PHARMA LTDMICRO LABS LTDMYLAN PHARMACEUTICALS INCNEPHRON PHARMACEUTICALS CORPORATIONSOMERSET THERAPEUTICS LLCSTRIDES PHARMA INTERNATIONAL AGWATSON LABORATORIES INCZYDUS LIFESCIENCES GLOBAL FZEZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
